Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy

INTRODUCTION: The purpose of this study was to evaluate the relationship between the kinetics of PSA decline after androgen deprivation therapy (ADT) initiation and overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (HSPC). METHODS: We identified a cohort of metastatic HS...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Choueiri, Toni K., Xie, Wanling, D’Amico, Anthony V., Ross, Robert W., Hu, Jim C., Pomerantz, Mark, Regan, Meredith M., Taplin, Mary-Ellen, Kantoff, Philip W., Sartor, Oliver, Oh, William K.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931827/
https://ncbi.nlm.nih.gov/pubmed/19152438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24064
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires